Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-02-15A Phase I Study of Bortezomib and Temozolomide in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-02-15A Phase I Study of the Biologic and Clinical Effects of 5-AZA-2'Deoxycytidine (DAC) in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-02-12A Phase I Trial of Bevacizumab and Bortezomib in Patients With Advanced Malignancy
-
CLINICAL_TRIALS study record update · 2013-02-12Phase II Pilot Study Of Rituximab Plus CHOP In Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
-
CLINICAL_TRIALS study record update · 2013-02-11A Dose Finding Study of R115777 (NSC 702818) in Patients With Advanced Hematologic Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-02-11A Phase I and Pharmacokinetic Study of Sequences of NSC 655649 (Rebeccamycin Analogue) and Cisplatin Without and With Granulocyte Colony-Stimulating Factor Support Every 21 Days
-
CLINICAL_TRIALS study record update · 2013-02-11A Phase I Study of BMS-247550 (NSC 710428) Given Weekly X 3 Every 4 Weeks in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-02-11A PHASE I STUDY OF PERILLYL ALCOHOL IN PATIENTS WITH REFRACTORY MALIGNANCIES (NSC #641066)
-
CLINICAL_TRIALS study record update · 2013-02-11PHASE I STUDY OF TOPOTECAN AND THORACIC RADIATION
-
CLINICAL_TRIALS study record update · 2013-02-11A Phase II Study Of Depsipeptide, A Histone Deacetylase Inhibitor, In Relapsed Or Refractory Mantle Cell Or Diffuse Large Cell Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-02-11PHASE II STUDY OF 9-AMINOCAMPTOTHECIN (9-AC/DMA, NSC# 603071) IN PREVIOUSLY TREATED HODGKIN'S DISEASE AND NON-HODGKIN'S LYMPHOMA: IWF GRADES A-H
-
CLINICAL_TRIALS study record update · 2013-02-11A Phase I Trial of Oral Penclomedine
-
CLINICAL_TRIALS study record update · 2013-02-11Phase I Trial of Humanized 1D10 Monoclonal Antibody (Hu1D10) In Patients With Relapsed Non-Hodgkin's Lymphoma (NHL)
-
CLINICAL_TRIALS study record update · 2013-02-08A Randomized Pre-Phase II Trial of Interleukin-2, Interleukin-12, or No Additional Therapy Following Response to Ifosfamide/Etoposide Chemotherapy for Refractory HIV-Associated Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-02-08Randomized Trial of CHOP Chemotherapy With or Without Rituximab (Chimeric Anti-CD20 Antibody) for HIV-Associated Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-02-08A Phase II Study of Cyclosporine in the Treatment of Angioimmunoblastic T-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-02-08A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplantation for the Treatment of Relapsed Non-Hodgkin and Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2013-02-06Arsenic Trioxide Alone or With ATRA (Vesanoid) for Resistant Hematologic Malignancy
-
CLINICAL_TRIALS study record update · 2013-02-05A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-02-05A PHASE I CLINICAL AND PHARMACOLOGIC EVALUATION OF PHENYLBUTYRATE IN PATIENTS WITH REFRACTORY SOLID TUMORS: STUDY OF CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE ON A THREE TIMES DAILY SCHEDULE
-
CLINICAL_TRIALS study record update · 2013-02-05A Phase II Study of 506U78 in Patients With Refractory or Relapsed T-Lineage Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphomas (LBL)
-
CLINICAL_TRIALS study record update · 2013-02-05A Phase II Trial of Flavopiridol (NSC 649890) Administered as a 72-Hour Continuous Infusion Every 2 Weeks in Patients With Previously Treated Intermediate and High Grade Non-Hodgkin's Lymphoma Including Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-02-05A PHASE I STUDY OF IRINOTECAN (CPT-11) WITH PHARMACOKINETIC MODULATION BY CYCLOSPORINE A AND PHENOBARBITAL
-
CLINICAL_TRIALS study record update · 2013-02-05PHASE II EVALUATION OF BRYOSTATIN-1 (NSC 339555) IN NON-HODGKIN'S LYMPHOMA
-
CLINICAL_TRIALS study record update · 2013-02-05Tandem Autologous Stem Cell Transplantation for Patients With Primary Progressive or Recurrent Hodgkin's Disease (A BMT Study), Phase II